Literature DB >> 19884969

Increased vascular O-GlcNAcylation augments reactivity to constrictor stimuli - VASOACTIVE PEPTIDE SYMPOSIUM.

Victor V Lima1, Fernanda R C Giachini, Fernando S Carneiro, Zidonia N Carneiro, Zuleica B Fortes, Maria Helena C Carvalho, R Clinton Webb, Rita C Tostes.   

Abstract

BACKGROUND: O-Linked N-acetylglucosaminylation (O-GlcNAcylation) plays a role in many aspects of protein function. Whereas elevated O-GlcNAc levels contribute to diabetes related end-organ damage, O-GlcNAcylation is also physiologically important. Because proteins that play a role in vascular tone regulation can be O-GlcNAcylated, we hypothesized that O-GlcNAcylation increases vascular reactivity to constrictor stimuli. METHODS AND
RESULTS: Aortas from male Sprague-Dawley rats and C57BL/6 mice were incubated for 24 h with vehicle or PugNAc (O-GlcNAcase inhibitor, 100muM). PugNAc incubation significantly increased O-GlcNAc-proteins, as determined by Western blot. PugNAc also increased vascular contractions to phenylephrine and serotonin, an effect not observed in the presence of L-NAME or in endothelium-denuded vessels. Acetylcholine-induced relaxation, but not that to sodium nitroprusside was decreased by PugNAc treatment, an effect accompanied by decreased levels of phosphorylated eNOS(Ser-1177) and Akt(Ser-473).
CONCLUSION: Augmented O-GlcNAcylation increases vascular reactivity to constrictor stimuli, possibly due to its effects on eNOS expression and activity, reinforcing the concept that O-GlcNAcylation modulates vascular reactivity and may play a role in pathological conditions associated with abnormal vascular function.

Entities:  

Keywords:  O-Linked N-acetylglucosaminylation (O-GlcNAc); PugNAc; eNOS; vascular reactivity

Year:  2008        PMID: 19884969      PMCID: PMC2630260          DOI: 10.1016/j.jash.2008.06.001

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  32 in total

Review 1.  Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging.

Authors:  Edward G Lakatta
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

2.  Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells.

Authors:  Natasha E Zachara; Niall O'Donnell; Win D Cheung; Jessica J Mercer; Jamey D Marth; Gerald W Hart
Journal:  J Biol Chem       Date:  2004-05-11       Impact factor: 5.157

3.  Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise.

Authors:  Garrett E Whitworth; Matthew S Macauley; Keith A Stubbs; Rebecca J Dennis; Edward J Taylor; Gideon J Davies; Ian R Greig; David J Vocadlo
Journal:  J Am Chem Soc       Date:  2007-01-24       Impact factor: 15.419

4.  Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction.

Authors:  Biljana Musicki; Melissa F Kramer; Robyn E Becker; Arthur L Burnett
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-05       Impact factor: 11.205

5.  Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance.

Authors:  L F Hebert; M C Daniels; J Zhou; E D Crook; R L Turner; S T Simmons; J L Neidigh; J S Zhu; A D Baron; D A McClain
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

6.  A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-D glucosaminidase is associated with type 2 diabetes in Mexican Americans.

Authors:  Donna M Lehman; Dong-Jing Fu; Angela B Freeman; Kelly J Hunt; Robin J Leach; Teresa Johnson-Pais; Jeanette Hamlington; Thomas D Dyer; Rector Arya; Hanna Abboud; Harald H H Göring; Ravindranath Duggirala; John Blangero; Robert J Konrad; Michael P Stern
Journal:  Diabetes       Date:  2005-04       Impact factor: 9.461

7.  Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.

Authors:  Keith Vosseller; Lance Wells; M Daniel Lane; Gerald W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

8.  17Beta-oestradiol partially attenuates the inhibition of nitric oxide synthase-3 by advanced glycation end-products in human platelets.

Authors:  Lu Chen; Yuan Liu; Bota Cui; Qiongyu Mi; Yan Huang; Leming Fan; Qi Chen; James Tang; Albert Ferro; Yong Ji
Journal:  Clin Exp Pharmacol Physiol       Date:  2007-10       Impact factor: 2.557

9.  Neutrophils exhibit rapid agonist-induced increases in protein-associated O-GlcNAc.

Authors:  Zachary T Kneass; Richard B Marchase
Journal:  J Biol Chem       Date:  2004-08-20       Impact factor: 5.157

10.  Regulation of the inositol 1,4,5-trisphosphate receptor type I by O-GlcNAc glycosylation.

Authors:  Juliana Rengifo; Craig J Gibson; Eva Winkler; Thibault Collin; Barbara E Ehrlich
Journal:  J Neurosci       Date:  2007-12-12       Impact factor: 6.167

View more
  18 in total

1.  O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway.

Authors:  Victor V Lima; Fernanda R Giachini; Fernando S Carneiro; Maria Helena C Carvalho; Zuleica B Fortes; R Clinton Webb; Rita C Tostes
Journal:  Cardiovasc Res       Date:  2010-10-26       Impact factor: 10.787

Review 2.  The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.

Authors:  Natasha E Zachara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-27       Impact factor: 4.733

Review 3.  Protein O-GlcNAcylation and cardiovascular (patho)physiology.

Authors:  Susan A Marsh; Helen E Collins; John C Chatham
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

4.  High-fat diet increases O-GlcNAc levels in cerebral arteries: a link to vascular dysfunction associated with hyperlipidaemia/obesity?

Authors:  Victor V Lima; Fernanda R Giachini; Takayuki Matsumoto; Weiguo Li; Alecsander F M Bressan; Dhruv Chawla; R Clinton Webb; Adviye Ergul; Rita C Tostes
Journal:  Clin Sci (Lond)       Date:  2016-02-29       Impact factor: 6.124

5.  O-GlcNAcylation: a novel post-translational mechanism to alter vascular cellular signaling in health and disease: focus on hypertension.

Authors:  Victor V Lima; Christiné S Rigsby; David M Hardy; R Clinton Webb; Rita C Tostes
Journal:  J Am Soc Hypertens       Date:  2009 Nov-Dec

Review 6.  O-GlcNAcylation: a novel pathway contributing to the effects of endothelin in the vasculature.

Authors:  Victor V Lima; Fernanda R Giachini; David M Hardy; R Clinton Webb; Rita C Tostes
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-11-10       Impact factor: 3.619

7.  O-GlcNAcylation contributes to augmented vascular reactivity induced by endothelin 1.

Authors:  Victor V Lima; Fernanda R Giachini; Fernando S Carneiro; Zidonia N Carneiro; Mohamed A Saleh; David M Pollock; Zuleica B Fortes; Maria Helena C Carvalho; Adviye Ergul; R Clinton Webb; Rita C Tostes
Journal:  Hypertension       Date:  2009-11-30       Impact factor: 10.190

8.  O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice.

Authors:  Ayako Makino; Anzhi Dai; Ying Han; Katia D Youssef; Weihua Wang; Reshma Donthamsetty; Brian T Scott; Hong Wang; Wolfgang H Dillmann
Journal:  Am J Physiol Cell Physiol       Date:  2015-08-12       Impact factor: 4.249

Review 9.  O-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter?

Authors:  Victor V Lima; Kathryn Spitler; Hyehun Choi; R Clinton Webb; Rita C Tostes
Journal:  Clin Sci (Lond)       Date:  2012-10       Impact factor: 6.124

10.  Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing.

Authors:  Gopi Krishna Kolluru; Shyamal C Bir; Christopher G Kevil
Journal:  Int J Vasc Med       Date:  2012-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.